A life sciences company located in Fremantle that supplies a wide range of sequencing and mutation detection products and services to the global market. It was founded in 2002 by Dr David Sayer and Dr Damian Goodridge and has established itself as a leader in its field with over 200 laboratories using its technology. In January 2016 the business was acquired by American company Illumina, which now owns all Conexio shares. The acquisition will still use the Conexio brand name with some of its products.
